Novamed, Ltd. is a privately owned Israeli life science company founded in December 1995. Since its inception Novamed has been committed to the development of innovative, proprietary diagnostic systems with worldwide marketing potential.
Novamed has become an important player in selected markets by combining user need for a particular application with a cost-effective product. Such products include the patented and FDA approved DipStreak? and Diaslide? culture devices for rapid ...
Introduction:
Density gradient centrifugation of whole blood on a polysucrose - sodium metrizoate medium is the method of ...
Group B streptococci are most notable for their role in causing neonatal sepsis and meningitis. Two forms of neonatal ...
read moreINTENDED USE
Diaslide® Urine Culture Device (UCD) is a semi-quantitative screening culture device for detecting, ...
Novamed provides a variety of microbiological supplies.
We manufacture Prepared Culture Media, Stains and Reagents, ...




sending
enquiry |